Alembic Pharmaceuticals Limited (APLLTD):企業概要、財務及び戦略的SWOT分析

◆英語タイトル:Alembic Pharmaceuticals Limited (APLLTD) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDPH51841FSA
◆発行会社(調査会社):GlobalData
◆発行日:2015年1月9日
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:インド
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD300 ⇒換算¥32,400見積依頼/購入/質問フォーム
Site License(同一国内共有可)USD600 ⇒換算¥64,800見積依頼/購入/質問フォーム
Global Site License(複数国内共有可)USD900 ⇒換算¥97,200見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary

Alembic Pharmaceuticals Limited (Alembic Pharma) is an integrated pharmaceutical company. It undertakes the development, manufacturing and marketing of pharmaceutical products, active pharmaceutical ingredients and intermediates. The company offers products and services in five divisions, namely, active pharmaceutical ingredients, bulk pharma chemicals, formulations, herbal nutraceuticals, veterinary and contract research services. Alembic Pharma holds expertise in the Macrolides segment of anti-infective drugs. It offers active pharmaceutical ingredients and other drugs in the therapeutic areas of anti infectives, cardio vascular, musculoskeletol, erectile dysfunction and gastro intestinal. The company operates two manufacturing facilities in Vadodara, Gujarat and Baddi, Himachal Pradesh. Alembic Pharmaceuticals is headquartered in Vadodara, Gujarat, India.

Alembic Pharmaceuticals Limited Key Recent Developments

Oct 29, 2013: Indian Department of Pharmaceuticals Rejects Review Applications Over Fixed Ceiling Price Of Drugs
Oct 25, 2013: Alembic Pharmaceuticals announces for Quarter ended 3oth June 2013
Sep 13, 2013: Alembic Appoints R. C. Saxena as Non-Executive Independent Director
Aug 07, 2013: Alembic Pharmaceuticals Limited announces for Quarter ended 30th June 2013
May 02, 2013: Alembic Pharma Reports Revenue Of INR15.3 Billion In Fiscal 2013

This comprehensive SWOT profile of Alembic Pharmaceuticals Limited provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Alembic Pharmaceuticals Limited including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

【レポートの目次】

Table of Contents

Section 1 – About the Company

Alembic Pharmaceuticals Limited – Key Information
Alembic Pharmaceuticals Limited – Overview
Alembic Pharmaceuticals Limited – Key Employees
Alembic Pharmaceuticals Limited – Key Employee Biographies
Alembic Pharmaceuticals Limited – Key Operational Heads
Alembic Pharmaceuticals Limited – Major Products and Services
Alembic Pharmaceuticals Limited – History
Alembic Pharmaceuticals Limited – Company Statement
Alembic Pharmaceuticals Limited – Locations And Subsidiaries
Alembic Pharmaceuticals Limited – Key Manufacturing facilities
Head Office
Other Locations & Subsidiaries

Section 2 – Company Analysis

Alembic Pharmaceuticals Limited – Business Description
Alembic Pharmaceuticals Limited – Corporate Strategy
Alembic Pharmaceuticals Limited – SWOT Analysis
SWOT Analysis – Overview
Alembic Pharmaceuticals Limited – Strengths
Alembic Pharmaceuticals Limited – Weaknesses
Alembic Pharmaceuticals Limited – Opportunities
Alembic Pharmaceuticals Limited – Threats
Alembic Pharmaceuticals Limited – Key Competitors

Section 3 – Company Financial Performance Charts

Alembic Pharmaceuticals Limited – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts

Section 4 – Appendix

Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

Note*: Some sections may be missing if data is unavailable for the company

List of Tables

Alembic Pharmaceuticals Limited, Key Information
Alembic Pharmaceuticals Limited, Key Ratios
Alembic Pharmaceuticals Limited, Share Data
Alembic Pharmaceuticals Limited, Major Products and Services
Alembic Pharmaceuticals Limited, History
Alembic Pharmaceuticals Limited, Key Employees
Alembic Pharmaceuticals Limited, Key Employee Biographies
Alembic Pharmaceuticals Limited, Key Operational Heads
Alembic Pharmaceuticals Limited, Other Locations
Alembic Pharmaceuticals Limited, Subsidiaries
Alembic Pharmaceuticals Limited, Key Manufacturing facilities
Alembic Pharmaceuticals Limited, Key Competitors
Alembic Pharmaceuticals Limited, SWOT Analysis
Alembic Pharmaceuticals Limited, Ratios based on current share price
Alembic Pharmaceuticals Limited, Annual Ratios
Alembic Pharmaceuticals Limited, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures

Alembic Pharmaceuticals Limited, Performance Chart
Alembic Pharmaceuticals Limited, Ratio Charts

★海外企業調査レポート[Alembic Pharmaceuticals Limited (APLLTD):企業概要、財務及び戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Idera Pharmaceuticals Inc (IDRA):製薬・医療:M&Aディール及び事業提携情報
    Summary Idera Pharmaceuticals Inc. (Idera) is a clinical stage biopharmaceutical company, which focuses on the discovery, development and commercialization of drugs for the treatment of cancer and rare diseases. It develops DNA and RNA based drug candidates aimed at toll-like receptors (TLR) for the …
  • GenVault Corporation:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' GenVault Corporation Mergers an …
  • Greensmith Energy Management Systems LLC-エネルギー分野:企業M&A・提携分析
    Summary Greensmith Energy Management Systems, LLC (Greensmith) is a provider of energy storage management and services. The company specializes in software and control solutions to operate and manage Distributed Energy Storage Systems (DESS) for utility-scale, C&I or Micro-grid deployments. It offer …
  • The Coca-Cola Company:企業の戦略・SWOT・財務分析
    SummaryThe Coca-Cola Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Key F …
  • Dino Polska S.A (DNP):企業の財務・戦略的SWOT分析
    Dino Polska S.A (DNP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • CSL Limited:企業のM&A・事業提携・投資動向
    CSL Limited - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's CSL Limited Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, ca …
  • Sumitomo Metal Mining Co Ltd:戦略・SWOT・企業財務分析
    Sumitomo Metal Mining Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Sumitomo Metal Mining Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Perennial International Limited (725):企業財務及び戦略的SWOT分析
    Summary Perennial International Limited (Perennial) is an electrical equipment company that manufactures electric cable and wire products. The company’s products include power cord, power cord cable sets, cables and wire, wire harness and plastic resins. It offers services such as management, sales …
  • InterContinental Hotels Group Plc:企業の戦略・SWOT・財務情報
    InterContinental Hotels Group Plc - Strategy, SWOT and Corporate Finance Report Summary InterContinental Hotels Group Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • Saft Groupe SA:企業の戦略的SWOT分析
    Saft Groupe SA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and service …
  • Caperio Holding AB (publ) (CAPE):企業概要、財務及び戦略的SWOT分析
    Summary Caperio Holding AB (publ) (Caperio) is an information technology company. The company provides information technology solutions and implements projects. It offers network solutions such as analysis, advice, design, installation, and management of networks in the areas of wireless networks, n …
  • Aurobindo Pharma Ltd (AUROPHARMA):企業財務及び戦略的SWOT分析
    Summary Aurobindo Pharma Ltd (Aurobindo Pharma) is a pharmaceutical company that develops, manufactures and exports generic pharmaceuticals and active pharmaceutical ingredients. The company offers active pharma ingredients, formulations, antibiotics, anti-retrovirals, anti- allergics, HIVs, peptide …
  • Gunvor Group Limited:企業の戦略的SWOT分析
    Gunvor Group Limited - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • Centers for Disease Control and Prevention-製薬・医療分野:企業M&A・提携分析
    Summary Centers for Disease Control and Prevention (CDC), a subsidiary of US Department of Health and Human Services is a public health institute that offers health, safety and security threat management solutions. The institute provides health information to fight diseases and support communities f …
  • Sunshine Biopharma, Inc. (SBFM):企業概要、財務及び戦略的SWOT分析
    Summary Sunshine BioPharma, Inc. (Sunshine BioPharma) is a pharmaceutical company. The company conducts research, development and commercialization of drugs for the treatment of various forms of cancer. Its initial drug candidate is Adva-27a, which is a small molecule that has proven efficient again …
  • PATRIZIA Immobilien AG:企業の戦略・SWOT・財務分析
    SummaryPATRIZIA Immobilien AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Key …
  • UNIQA Ukraine:企業概要・SWOT分析
    This report is a crucial resource for industry executives and anyone looking to access key information about "UNIQA Ukraine" The report utilizes a wide range of primary and secondary sources, which are analyzed and presented in a consistent and easily accessible format. Timetric strictly follows a s …
  • Comverge, Inc.:企業のM&A・提携動向(エネルギー分野)
    Summary Comverge, Inc. (Comverge) is a clean energy company. It specializes in the provision of innovative solutions for peak and base load capacity to electric utilities, grid operators and associated electricity markets. It provides smart grid solutions to utilities and other energy customers cons …
  • Recordati SpA (REC):製薬・医療:M&Aディール及び事業提携情報
    Summary Recordati SpA (Recordati), a subsidiary of Fimei SpA is a pharmaceutical company that researches, develops, manufactures and markets pharmaceuticals. The company offers pharmaceuticals for cardiovascular diseases, dermatology, central nervous system disorders, musculo-skeletal disorders and …
  • Noxilizer, Inc.:企業のM&A・提携動向(医療機器分野)
    Summary Noxilizer, Inc. (Noxilizer) is a medical device company that manufactures and markets sterilization equipment. The company offers products such as industrial nitrogen dioxide sterilizer and biodecontamination systems. It provides services including contract sterilization services, installati …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆